Soleus Capital Master Fund, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for C4 Therapeutics, Inc Common Stock, par value $0.0001 per share (CCCC)

Filing Manager
Soleus Capital Master Fund, L.P.
Reporting Manager
Soleus Capital Master Fund, L.P.
Security
C4 Therapeutics, Inc Common Stock, par value $0.0001 per share
Symbol
CCCC
Shares outstanding
103,722,322 shares
Disclosed Ownership
10,361,860 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2026, 17:02:01 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (9)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Private Equity Fund III, L.P. 5.9% 6,072,822 0 6,072,822 /s/ Guy Levy Guy Levy/Managing Member
Soleus Private Equity GP III, LLC 5.9% 6,072,822 0 6,072,822 /s/ Guy Levy Guy Levy/Managing Member
Soleus PE GP III, LLC 5.9% 6,072,822 0 6,072,822 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Master Fund, L.P. 10% 10,361,860 0 10,361,860 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 10% 10,361,860 0 10,361,860 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 10% 10,361,860 0 10,361,860 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 10% 10,334,114 0 10,334,114 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 10% 10,334,114 0 10,334,114 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 10% 10,334,114 0 10,334,114 /s/ Guy Levy Guy Levy